Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Melanoma Stage IV|Sarcoma|Squamous Cell Carcinoma|Pancreatic Cancer Stage IV|Prostate Cancer|Breast Cancer Stage IV
Interventions: DIAGNOSTIC_TEST: CTC isolation by HSP70
Sponsor: Charite University, Berlin, Germany
Collaborators: Klinikum rechts der Isar, TU München, (TUM), Munich, Germany.